The potential use of MMP inhibitors to treat CNS diseases

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.3, 1999-03, pp. : 255-268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurogenic Drugs and Compounds to Treat CNS Diseases and Disorders

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 1, 2011-01 ,pp. : 35-37

Bentham Science Publishers

Access to resources Recommend Favorite

Calpain and Its Involvement in the Pathophysiology of CNS Injuries and Diseases: Therapeutic Potential of Calpain Inhibitors for Prevention of Neurodegeneration

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 3, 2003-06 ,pp. : 173-189

Bentham Science Publishers

Access to resources Recommend Favorite

MMP/ADAM inhibitors: therapeutic potential for psoriasis

By Yokota Koichi Nishimura Shin-Ichiro

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 421-435

Informa Healthcare

Access to resources Recommend Favorite

Matrix Metalloproteinase Knockout Studies and the Potential Use of Matrix Metalloproteinase Inhibitors in the Rheumatic Diseases

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-06 ,pp. : 363-375

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in potential therapeutic uses of inhibitors of CNS selective amino acid transporters

By Armer R.E. Miller D.J.

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 4, 2001-04 ,pp. : 563-572

Informa Healthcare

Access to resources Recommend Favorite